James P. Daubert

Active 1990–2025

72
Papers
34,596
Citations
56
h-index
71
i10-index

Citations

Citations per year for James P. Daubert1981: 1 citations1982: 1 citations1986: 1 citations1991: 2 citations1992: 2 citations1993: 4 citations1994: 4 citations1995: 2 citations1996: 4 citations1997: 6 citations1998: 20 citations1999: 25 citations2000: 28 citations2001: 40 citations2002: 34 citations2003: 88 citations2004: 110 citations2005: 153 citations2006: 196 citations2007: 147 citations2008: 210 citations2009: 203 citations2010: 192 citations2011: 254 citations2012: 263 citations2013: 257 citations2014: 266 citations2015: 253 citations2016: 182 citations2017: 201 citations2018: 160 citations2019: 562 citations2020: 606 citations2021: 565 citations2022: 394 citations2023: 271 citations2024: 426 citations2025: 211 citations2026: 9 citations1983–1985: no citations, so these years are not shown1987–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,209 citing papers, 25.4% of this breakdownUnited Kingdom: 702 citing papers, 8.1% of this breakdownItaly: 694 citing papers, 8% of this breakdownNetherlands: 547 citing papers, 6.3% of this breakdownGermany: 528 citing papers, 6.1% of this breakdownCanada: 406 citing papers, 4.7% of this breakdownFrance: 334 citing papers, 3.8% of this breakdownSpain: 255 citing papers, 2.9% of this breakdownSwitzerland: 231 citing papers, 2.7% of this breakdownAustralia: 227 citing papers, 2.6% of this breakdownChina: 223 citing papers, 2.6% of this breakdownJapan: 187 citing papers, 2.1% of this breakdown
0%25.4%Other 24.7%

Fields

  • Medicine94.3%
  • Biochemistry, Genetics and Molecular Biology2.4%
  • Engineering1.2%
  • Computer Science0.7%
  • Neuroscience0.4%
  • Health Professions0.3%
  • Other0.7%

Topics

  • Cardiac pacing and defibrillation studies15.4%
  • Cardiac electrophysiology and arrhythmias12.7%
  • Cardiac Arrhythmias and Treatments9%
  • Cardiovascular Effects of Exercise7.4%
  • Cardiomyopathy and Myosin Studies6%
  • Cardiovascular Function and Risk Factors4.8%
  • Other44.7%

Coauthors

All papers

Open in search
  1. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Heart Rhythm 2019 cited by 806

  2. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

    Authors: , , , , , , , , , - New England Journal of Medicine 2002 cited by 6,873

  3. Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 3,139

  4. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2010 cited by 2,657

  5. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2010 cited by 1,599

  6. Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1996 cited by 4,170

  7. Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2004 cited by 2,068

  8. Reduction in Inappropriate Therapy and Mortality through ICD Programming

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 1,361

  9. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2011 cited by 838

  10. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction

    Authors: , , , , , , , , , , , , , , , , , , , - Heart Rhythm 2017 cited by 148

  11. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score

    Authors: , , , , , , , , , , , , , - European Heart Journal 2020 cited by 130

  12. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Heart Rhythm 2019 cited by 185

  13. Catheter ablation of atrial fibrillation in patients with diabetes mellitus

    Authors: , , , , , , , , , , , , , , , , , , , , , - Heart Rhythm O2 2020 cited by 41

  14. Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2000 cited by 1,040

  15. Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 352

  16. Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 116

  17. Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA 2007 cited by 800

  18. New Concepts in Sudden Cardiac Arrest to Address an Intractable Epidemic

    Authors: , , - Journal of the American College of Cardiology 2019 cited by 67

  19. Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator

    Authors: , , , , , , , , , - Circulation 2004 cited by 592

  20. Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2008 cited by 804

  21. Identification of Undetected Monogenic Cardiovascular Disorders

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 cited by 32

  22. Are Implantable Cardioverter Defibrillator Shocks a Surrogate for Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy?

    Authors: , , , , , , , , , - Circulation 2006 cited by 295

  23. Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2004 cited by 229

  24. Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial

    Authors: , , , , , , , , , , , , , - Journal of Cardiovascular Electrophysiology 2014 cited by 94